These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 28799485)

  • 21. A systematic review of head-to-head trials of approved monoclonal antibodies used in cancer: an overview of the clinical trials agenda.
    Luo J; Nishikawa G; Prasad V
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2303-2311. PubMed ID: 31396700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: a lesson from autoimmune diseases.
    Talotta R; Rucci F; Canti G; Scaglione F
    Immunotherapy; 2019 Feb; 11(3):241-254. PubMed ID: 30730275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of chimeric and humanized antibodies to autoimmune diseases therapy].
    Noguchi H
    Nihon Rinsho; 1997 Jun; 55(6):1549-56. PubMed ID: 9200947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Licensed monoclonal antibodies and associated challenges.
    Khan AH; Sadroddiny E
    Hum Antibodies; 2015 Dec; 23(3-4):63-72. PubMed ID: 27472864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM
    Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacology and therapeutic applications of monoclonal antibodies.
    Castelli MS; McGonigle P; Hornby PJ
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00535. PubMed ID: 31859459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoclonal antibodies and therapeutics].
    Desgranges C
    Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic monoclonal antibodies in ophthalmology.
    Rodrigues EB; Farah ME; Maia M; Penha FM; Regatieri C; Melo GB; Pinheiro MM; Zanetti CR
    Prog Retin Eye Res; 2009 Mar; 28(2):117-44. PubMed ID: 19114125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of covariate effects on pharmacokinetics of monoclonal antibodies in oncology.
    Bajaj G; Suryawanshi S; Roy A; Gupta M
    Br J Clin Pharmacol; 2019 Sep; 85(9):2045-2058. PubMed ID: 31140642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of therapeutic antibodies for the treatment of diseases.
    Lu RM; Hwang YC; Liu IJ; Lee CC; Tsai HZ; Li HJ; Wu HC
    J Biomed Sci; 2020 Jan; 27(1):1. PubMed ID: 31894001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunology proves a great success for treating systemic autoimmune diseases - a perspective on immunopharmacology: IUPHAR Review 23.
    Ishii M
    Br J Pharmacol; 2017 Jul; 174(13):1875-1880. PubMed ID: 28299772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers.
    Paci A; Desnoyer A; Delahousse J; Blondel L; Maritaz C; Chaput N; Mir O; Broutin S
    Eur J Cancer; 2020 Mar; 128():107-118. PubMed ID: 32037061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular, biologic, and pharmacokinetic properties of monoclonal antibodies: impact of these parameters on early clinical development.
    Mascelli MA; Zhou H; Sweet R; Getsy J; Davis HM; Graham M; Abernethy D
    J Clin Pharmacol; 2007 May; 47(5):553-65. PubMed ID: 17379759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the current use of rituximab in autoimmune diseases.
    Gürcan HM; Keskin DB; Stern JN; Nitzberg MA; Shekhani H; Ahmed AR
    Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approved monoclonal antibodies for cancer therapy.
    Boyiadzis M; Foon KA
    Expert Opin Biol Ther; 2008 Aug; 8(8):1151-8. PubMed ID: 18613766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies in oncology.
    Pillay V; Gan HK; Scott AM
    N Biotechnol; 2011 Sep; 28(5):518-29. PubMed ID: 21473941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Development and Regulatory Pathways of Monoclonal Antibodies in Japan.
    Liao H; Li Z
    Ther Innov Regul Sci; 2022 Mar; 56(2):173-183. PubMed ID: 34825323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody-based strategies in autoimmunity and transplantation.
    Chatenoud L
    Methods Mol Med; 2005; 109():297-328. PubMed ID: 15585929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating multiple sclerosis with monoclonal antibodies.
    Buttmann M; Rieckmann P
    Expert Rev Neurother; 2008 Mar; 8(3):433-55. PubMed ID: 18345973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering therapeutic monoclonal antibodies.
    Liu XY; Pop LM; Vitetta ES
    Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.